VOYA INVESTMENT MANAGEMENT LLC
Position in LXRX — Lexicon Pharmaceuticals, Inc.
CIK 1068837
ATLANTA, GA
Position in LXRX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$114,650
+$108,246 QoQ
Shares Held
47,771
+243.1% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#74
of 148 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in LXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VOYA INVESTMENT MANAGEMENT LLC holds $1,414,582,516 across 196 Biotechnology names. LXRX ranks #151 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
505,219 | $250,957,432 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
571,618 | $70,068,932 | |
| 3 | SRRK |
Scholar Rock Holding Corp
|
890,607 | $48,983,385 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
124,442 | $46,251,357 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
819,253 | $45,009,759 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
539,319 | $43,992,249 | |
| 7 | PRAX |
Praxis Precision Medicines, Inc.
|
122,227 | $40,920,376 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
65,505 | $40,844,986 |
All Filings in LXRX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $114,650 | 47,771 | Shares | Defined | 2026-08-12 | |
| 2025-03-31 | $6,404 | 13,922 | Shares | Defined | 2025-06-18 | |
| 2024-12-31 | $28,429 | 38,418 | Shares | Defined | 2025-05-02 | |
| 2024-09-30 | $60,316 | 38,418 | Shares | Defined | 2025-02-07 | |
| 2024-06-30 | $66,605 | 39,646 | Shares | Defined | 2025-02-07 | |
| 2024-03-31 | $69,525 | 28,969 | Shares | Defined | 2025-02-07 | |
| 2023-12-31 | $57,159 | 37,359 | Shares | Defined | 2025-02-07 | |
| 2023-09-30 | $40,721 | 37,359 | Shares | Defined | 2025-02-07 | |
| 2023-06-30 | $85,552 | 37,359 | Shares | Defined | 2025-02-07 | |
| 2023-03-31 | $79,414 | 32,681 | Shares | Defined | 2025-02-07 | |
| 2022-12-31 | $62,420 | 32,681 | Shares | Defined | 2025-02-07 | |
| 2022-09-30 | $78,434 | 32,681 | Shares | Defined | 2025-02-07 | |
| 2022-06-30 | $49,012 | 26,351 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $64,747 | 30,980 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $114,952 | 29,176 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $129,422 | 26,907 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $123,503 | 26,907 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $119,748 | 20,400 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $75,534 | 22,086 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $18,607 | 12,922 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $25,844 | 12,922 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $42,757 | 21,927 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||